Navigation Links
QBC Diagnostics Announces the Availability of the ParaLens Advance LED Fluorescence Microscopy Attachment
Date:1/19/2011

PORT MATILDA, Pa., Jan. 19, 2011 /PRNewswire/ -- QBC Diagnostics is pleased to announce the release of the QBC ParaLens Advance, a breakthrough product that can easily upgrade any compound light microscope for LED fluorescence microscopy.

The ParaLens Advance builds on the proven success of the ParaLens Microscope Attachment, which introduced the benefits of durable, easy-to-power LED fluorescence microscopy to thousands of labs around the world. The ParaLens Advance improves on its predecessor with a more powerful light source, equivalent to a 100 Watt mercury vapor bulb, and a patent-pending removable filter set arm that allows users to quickly change between objectives whenever necessary.

LED fluorescence microscopy has demonstrated increased sensitivity and speed in numerous research and clinical applications, including the detection of infectious diseases such as tuberculosis and malaria. Recently, the World Health Organization (WHO) recommended that all labs around the world adopt LED fluorescence microscopy for tuberculosis screening.

Craig Stout, QBC Diagnostics Vice President and General Manager said, "The ParaLens Advance was developed to provide the benefits of LED fluorescence microscopy to more users around the world. By upgrading their existing microscopes, these users can meet the WHO's recommendation without investing in unnecessary new equipment."

For more information on the ParaLens Advance, please contact QBC Diagnostics at +1-814-692-7661 or via email at paralensadvance@qbcdiag.com. Product information for the ParaLens Advance is available on the QBC Diagnostics website at www.qbcdiagnostics.com/paralensadvance.

About QBC Diagnostics

QBC Diagnostics is a privately held company headquartered in Port Matilda, Pennsylvania, USA. The company manufactures a line of complete blood count analyzers and fluorescence microscopy products. Additional information can be found by visiting the company website (www.qbcdiagnostics.com) or by calling +1-814-692-7661.


'/>"/>
SOURCE QBC Diagnostics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children
2. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
3. Roche Diagnostics HIV Viral Load Test Used in Clinical Trials for Isentress, a New Class of HIV Drug
4. Two Point of Care Tests From Quest Diagnostics Receive FDA 510(k) Clearance
5. Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease
6. Xenomics Announces Issuance of a US Patent That Covers Use of Transrenal Nucleic Acid Technology for Infectious Disease Diagnostics and Monitoring
7. Study of Pathwork Diagnostics Tissue of Origin Test Published in the Journal of Molecular Diagnostics: Investigates Test Reproducibility in Multiple Labs to Determine Primary Tumor in Cancer Cases
8. Siemens Medical Solutions Diagnostics Inks Agreement with KreLo Medical Diagnostics to Expand Thyroid Immunoassay Menu
9. Siemens Healthcare Diagnostics Launches B12, Folate, and Ferritin Tests on Its Dimension vista Intelligent Lab System
10. Focus Diagnostics Launches Laboratory Test for Chikungunya Virus
11. Bertrand Study Finds Significant Value in Breast-Specific Gamma Imaging (BSGI) as an Adjunctive Procedure in Breast Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... PARK , Israel , December 7, 2016 ... today the signing of a memorandum of understanding with Korean company ... between the companies will assist in expediting Kadimastem,s entry into international ... innovative treatment for severe diseases in general and ALS and diabetes ... , , ...
(Date:12/7/2016)... , Dec. 7, 2016 Boehringer Ingelheim ... in patients with unresectable malignant pleural mesothelioma (MPM) ... The data, presented at the 17 th ... Vienna , showed nintedanib plus pemetrexed/cisplatin ... plus pemetrexed/cisplatin, with a significantly improved PFS (9.4 ...
(Date:12/7/2016)... , Dec. 7, 2016  Ionis Pharmaceuticals, Inc. (NASDAQ: ... will present a company overview at the BMO Capital Markets Prescriptions ... New York, NY . A live webcast of ... of the Ionis website.  The replay will be available within 48 ... ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... 2016 , ... It is vital for any lab to secure funding, and ... team at Beckman Coulter has designed Kaluza, templates with advanced analytical tools to streamline ... operate in a GLP (Good Laboratory Practice) fashion. , With features designed to simplify ...
(Date:12/7/2016)... ... ... came time to blow out his candles on his 14th birthday, Estefano Reano had only ... team at Joe DiMaggio Children’s Hospital surprised his family with a phone call that made ... , “He was playing at home, when we got the phone call telling us there ...
(Date:12/7/2016)... ... ... One of two inventors from Glen Burnie, Md., has a granddaughter who ... is why the co-inventor and I have designed a new and better way to ... of the patent-pending AV-AIR, a device that serves as an alternative to conventional methods ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... that its fully redesigned website, which launched October 17, 2016, features comprehensive information ... design and easy-to-navigate layout. Visitors and patients can discover the latest clinical dermatology ...
(Date:12/7/2016)... City, CA (PRWEB) , ... December 07, 2016 , ... ... during the holidays and winter seasons. One major study analyzing heart attacks among ... compared to August of a given year. We would all agree of course–no time ...
Breaking Medicine News(10 mins):